Wellington Management Group LLP Acquires 4,983 Shares of Doximity, Inc. $DOCS

Wellington Management Group LLP boosted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 74.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,639 shares of the company's stock after acquiring an additional 4,983 shares during the period. Wellington Management Group LLP's holdings in Doximity were worth $675,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of DOCS. Hsbc Holdings PLC purchased a new position in Doximity during the 4th quarter valued at about $891,000. Northern Trust Corp lifted its position in Doximity by 9.4% during the 4th quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock valued at $77,906,000 after acquiring an additional 125,332 shares during the period. Schonfeld Strategic Advisors LLC purchased a new position in Doximity during the 4th quarter valued at about $726,000. Mercer Global Advisors Inc. ADV lifted its position in Doximity by 2.3% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,993 shares of the company's stock valued at $854,000 after acquiring an additional 360 shares during the period. Finally, AXA S.A. lifted its position in Doximity by 147.8% during the 4th quarter. AXA S.A. now owns 439,232 shares of the company's stock valued at $23,451,000 after acquiring an additional 262,004 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Performance

Shares of DOCS stock traded up $0.79 during trading hours on Friday, reaching $69.31. The company had a trading volume of 787,369 shares, compared to its average volume of 2,255,650. The business has a fifty day moving average price of $62.66 and a 200-day moving average price of $59.94. Doximity, Inc. has a one year low of $35.32 and a one year high of $85.21. The firm has a market cap of $12.98 billion, a PE ratio of 69.31, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period last year, the firm earned $0.28 earnings per share. Doximity's revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Analyst Ratings Changes

DOCS has been the subject of several recent analyst reports. Mizuho decreased their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a report on Friday, May 16th. Bank of America lifted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a "neutral" rating in a report on Wednesday, May 21st. Wells Fargo & Company lifted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a report on Monday, August 4th. Finally, BTIG Research raised shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price for the company in a report on Monday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and a consensus target price of $66.21.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director directly owned 6,360 shares in the company, valued at approximately $381,600. The trade was a 61.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of the business's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $63.00, for a total transaction of $315,000.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,000 shares of company stock worth $1,929,380 over the last three months. 31.30% of the stock is currently owned by company insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.